Position in GRFS
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$1,472
+$430 QoQ
Shares Held
208
+60.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#148
of 164 holders
Holding Since
Mar 2020
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GRFS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TD PRIVATE CLIENT WEALTH LLC holds $73,461,022 across 15 Drug Manufacturers - General names. GRFS ranks #15 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
68,085 | $17,132,909 | |
| 2 | JNJ |
Johnson & Johnson
|
40,175 | $10,203,244 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
65,996 | $8,337,934 | |
| 4 | MRK |
Merck & Co., Inc.
|
63,772 | $8,194,702 | |
| 5 | LLY |
ELI LILLY & Co
|
5,646 | $6,771,982 | |
| 6 | AMGN |
Amgen Inc
|
17,457 | $6,321,528 | |
| 7 | SNY |
Sanofi
|
130,032 | $5,547,165 | |
| 8 | PFE |
Pfizer Inc
|
217,302 | $5,232,632 |
All Filings in GRFS
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,472 | 208 | Shares | Defined | 2026-08-04 | |
| 2026-03-31 | $1,042 | 130 | Shares | Defined | 2026-04-27 | |
| 2025-12-31 | $224 | 24 | Shares | Defined | 2026-02-05 | |
| 2025-09-30 | $239 | 24 | Shares | Defined | 2025-10-27 | |
| 2021-09-30 | $1,957 | 134 | Shares | Defined | 2024-08-16 | |
| 2021-06-30 | $2,324 | 134 | Shares | Defined | 2024-08-16 | |
| 2021-03-31 | $2,316 | 134 | Shares | Defined | 2024-08-16 | |
| 2020-12-31 | $626 | 34 | Shares | Defined | 2024-08-16 | |
| 2020-09-30 | $589 | 34 | Shares | Defined | 2024-08-16 | |
| 2020-06-30 | $620 | 34 | Shares | Defined | 2024-08-16 | |
| 2020-03-31 | $684 | 34 | Shares | Defined | 2024-08-16 | |
| No filing history on record for this holder in this stock. | ||||||